Boston Scientific (BSX)
48.17
+0.00 (0.00%)
NYSE· Last Trade: Aug 27th, 4:40 AM EDT
On Aug. 26, 2026, a cyberattack halted order processing and shipping at the medical device maker, leaving investors uncertain about the speed of recovery and near-term shipment delays.
Via The Motley Fool · August 26, 2026
The medical device specialist was the victim of a cyberattack.
Via The Motley Fool · August 26, 2026
Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session.chartmill.com
Via Chartmill · August 26, 2026
What's going on in today's session: S&P500 moverschartmill.com
Via Chartmill · August 26, 2026
Boston Scientific (NYSE:BSX) Screens as a Decent Value with Strong Fundamentalschartmill.com
Via Chartmill · August 12, 2026
Boston Scientific (NYSE:BSX) Tops Q2 2026 Estimates on Adjusted EPS Beatchartmill.com
Via Chartmill · July 29, 2026
These S&P500 stocks are gapping in today's sessionchartmill.com
Via Chartmill · August 26, 2026
Top S&P500 movers in Wednesday's pre-market sessionchartmill.com
Via Chartmill · August 26, 2026
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.54% on an annualized basis producing an average annual return of 15.01%. Currently, Boston Scientific has a market capitalization of
Via Benzinga · August 17, 2026
Get insights into the top movers in the S&P500 index of Friday's pre-market session.chartmill.com
Via Chartmill · August 14, 2026
Habiger's $100,000 purchase expanded his direct holdings by 14%, signaling confidence despite the stock's recent weakness. The acquisition came as shares traded near their lowest levels in over a year.
Via The Motley Fool · August 10, 2026
Mahoney expanded his equity stake by 13% following a -54% one-year stock decline. His combined holdings now total ~1.6 million shares valued at $78.08 million.
Via The Motley Fool · August 10, 2026
WATCHMAN and Electrophysiology headwinds force guidance cut despite solid organic growth.
Via The Motley Fool · August 7, 2026
Stay updated with the S&P500 stocks that are on the move in today's after-hours session.chartmill.com
Via Chartmill · August 5, 2026
Boston Scientific's second quarter was shaped by healthy growth in its Interventional Cardiology, Endoscopy, and Neuromodulation businesses, which counterbal...
Via StockStory · August 5, 2026
These S&P500 stocks are gapping in today's sessionchartmill.com
Via Chartmill · August 3, 2026
Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q2 CY2026, with sales up 7.5% year on year to $5.44 billion. On...
Via StockStory · July 30, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · July 30, 2026
Boston Scientific (NYSE:BSX) reported second-quarter 2026 revenue growth at the high end of its guidance range and adjusted earnings per share above expectations, but lowered its full-year outlook as it faces slowing demand in its WATCHMAN left atrial appendage closure business and increased competi
Via MarketBeat · July 29, 2026
Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session.chartmill.com
Via Chartmill · July 29, 2026
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.chartmill.com
Via Chartmill · July 29, 2026
Get insights into the top movers in the S&P500 index of Wednesday's pre-market session.chartmill.com
Via Chartmill · July 29, 2026
Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 7.5% year on year to ...
Via StockStory · July 29, 2026
Medical device company Boston Scientific (NYSE:BSX) will be reporting earnings this Wednesday morning. Here’s what to expect. Boston Scientific beat analysts...
Via StockStory · July 27, 2026
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.23% on an annualized basis producing an average annual return of 13.77%. Currently, Boston Scientific has a market capitalization of
Via Benzinga · July 27, 2026
